{"SLR NAME":"Antibiotic prescribing in patients with COVID-19: a rapid review and meta-analysis","References":[{"title1":"Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Understanding of COVID-19 based on current evidence","References":[{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the coronavirus study group"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation (in Chinese)"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"The 2019-new coronavirus epidemic: evidence for virus evolution"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Cryo-EM structure of the SARS-CoV-2 spike in the prefusion conformation"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection","References":[{"title3":"Influenza A in immunocompromised patients"},{"title3":"Respiratory virus infections in adults with hematologic malignancies: a prospective study"},{"title3":"Risk factors for pneumonia in immunocompromised patients with influenza"},{"title3":"Outbreak of swine-origin influenza A (H1N1) virus infection:Mexico, March-April 2009"},{"title3":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection:California, April-May, 2009"},{"title3":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009"},{"title3":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy"},{"title3":"Influenza virus infection in adult solid organ transplant recipients"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans"},{"title3":"Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK"},{"title3":"Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection"},{"title3":"2009 H1n1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients"},{"title3":"The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients"},{"title3":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study"},{"title3":"Respiratory syncytial virus infection in immunocompromised adults"},{"title3":"The challenge of respiratory virus infections in hematopoietic cell transplant recipients"},{"title3":"Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency"},{"title3":"Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus"},{"title3":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1):United States, May-August 2009"},{"title3":"Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections"},{"title3":"Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza"},{"title3":"Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes"}]},{"title2":"Respiratory tract infections in the immunocompromised","References":[]},{"title2":"Epidemiological and clinical aspects of COVID-19; a narrative review","References":[{"title3":"Estimates of world-wide distribution of child deaths from acute respiratory infections"},{"title3":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016"},{"title3":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016"},{"title3":"Weekly epidemiological update on COVID-19 - 19 October 2021"},{"title3":"Guia de vigilancia epidemiologica - Emergencia de sude publica de importancia nacional pela doenca pelo coronavirus 2019"},{"title3":"A pandemia de COVID-19 no Brasil: cronica de uma crise sanitaria anunciada"},{"title3":"Covid-19 pandemic implications for food and nutrition security in Brazil"},{"title3":"Pandemia e desemprego no Brasil"},{"title3":"Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic"},{"title3":"COVID-19 e hospitalizacoes por SRAG no Brasil: uma comparacao ate a 12a semana epidemiologica de 2020"},{"title3":"How many more ? Under-reporting of the COVID-19 deaths in Brazil in 2020"},{"title3":"Clinical features and mortality in COVID-19 SARI versus non COVID-19 SARI cases from Western Rajasthan, India"},{"title3":"Excess mortality associated with COVID-19 in Brazil : 2020-2021"},{"title3":"Influenza: monitoramento ate a semana epidemiologica 52 de 2019"},{"title3":"Incidence of and mortality from COVID-19 in the older Brazilian population and its relationship with contextual indicators: an ecological study"},{"title3":"A importancia da gestao correta da condicao cronica na Atencao Primaria a Saude para o enfrentamento da COVID-19 em Uberlandia, Minas Gerais"},{"title3":"Bearing the brunt of covid-19: older people in low and middle income countries"},{"title3":"COVID-19 in long-term care facilities: an upcoming threat that cannot be ignored"},{"title3":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths"},{"title3":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis"},{"title3":"Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019"},{"title3":"Excess mortality and potential undercounting of COVID-19 deaths by demographic group in Ohio"},{"title3":"Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020"},{"title3":"Severe acute respiratory infection surveillance during the initial phase of the COVID-19 outbreak in north India: a comparison of COVID-19 to other SARI causes"},{"title3":"Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis"},{"title3":"Is diabetes mellitus associated with mortality and severity of COVID- 19? A meta-analysis"},{"title3":"China cardiovascular diseases report 2018: an updated summary"},{"title3":"COVID-19 and comorbidities: a systematic review and meta-analysis"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study"},{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"Excess mortality due to natural causes among whites and blacks during the COVID-19 pandemic in Brazil"},{"title3":"Do women consult more than men? A review of gender and consultation for back pain and headache"},{"title3":"Excess mortality in men and women in Massachusetts during the COVID-19 pandemic"},{"title3":"Women's health during the COVID-19 pandemic"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Race-related disparities in COVID-19 thrombotic outcomes: beyond social and economic explanations"},{"title3":"COVID-19: the great unequaliser"},{"title3":"Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden"},{"title3":"COVID-19: exposing and amplifying inequalities"},{"title3":"2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature"},{"title3":"Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review"},{"title3":"Colapso na saude em Manaus: o fardo de nao aderir as medidas nao farmacologicas de reducao da transmissao da COVID-19"},{"title3":"Estimating the early death toll of COVID-19 in the United States"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"SRAG por COVID-19 no Brasil: descricao e comparacao de caracteristicas demograficas e comorbidades com SRAG por influenza e com a populacao geral"},{"title3":"Seasonal dynamics of influenza in Brazil : the latitude effect"},{"title3":"COVID-19 e desenvolvimento sustentavel [livro eletronico] : avaliando a crise de olho na recuperacao : sumario executivo"},{"title3":"Avaliacao do sistema de vigilancia da sindrome respiratoria aguda grave (SRAG) com enfase em influenza, no Brasil, 2014 a 2016"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study","References":[]}]},{"title1":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","References":[{"title2":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282. Accessed March 22, 2020.","References":[]},{"title2":"Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy","References":[{"title3":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Disease (COVID-19):Chinese, 2020. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Accessed March 22, 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response [e-pub ahead of print. JAMA. https://doi.org/10.1001/jama.2020.4031. Accessed March 24, 2020."},{"title3":"Guidelines on the Therapeutic and Support Management of Patients with COVID-19 Coronavirus Infection. Edition 2.0, 12 March 2020. Available at: http://www.simit.org/medias/1568-covid19-vademecum-20.13.marzo.2020.pdf. Accessed March 22, 2020"},{"title3":"World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed March 22, 2020."},{"title3":"Naicker S, Yang C, Hwang S, et al. The novel Coronavirus 2019 pandemic and kidneys. Kidney Int, in press."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]"},{"title3":"Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 [e-pub ahead of print]. J Crit Care. https://doi.org/10.1016/j.jcrc.2020.03.005. Accessed March 23, 2020."},{"title3":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells"},{"title3":"Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression [e-pub ahead of print]. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkaa114. Accessed March 23, 2020."},{"title3":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [e-pub ahead of print]. Int J Antimicrob Agents. doi: 10.1016/j.ijantimicag.2020.105949. Accessed March 23, 2020."},{"title3":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282. Accessed March 22, 2020."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection"},{"title3":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [e-pub ahead of print]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994. Accessed March 22, 2020."},{"title3":"Cytokine release syndrome with chimeric antigen receptor T cell therapy"}]},{"title2":"The Novel Coronavirus Pneumoniae Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19):China. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Accessed March 22, 2020.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [e-pub ahead of print]. Int J Antimicrob Agents.https://doi.org/10.1016/j.ijantimicag.2020.105949. Accessed March 26, 2020.","References":[]},{"title2":"Cytokine release syndrome with chimeric antigen receptor T cell therapy","References":[{"title3":"Tisagenlecleucel in adult relapsed or refractory diffuse large b-cell lymphoma"},{"title3":"Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study"},{"title3":"The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma"},{"title3":"The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions"},{"title3":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management"},{"title3":"Cytokine release syndrome"},{"title3":"Toxicities of chimeric antigen receptor T cells: recognition and management"},{"title3":"Current concepts in the diagnosis and management of cytokine release syndrome"},{"title3":"Cytokine release syndrome with chimeric antigen receptor t cell therapy"},{"title3":"Case report: local cytokine release syndrome in an acute lymphoblastic leukemia patient after treatment with chimeric antigen receptor t-cell therapy: a possible model, literature review and perspective"},{"title3":"Cervical edema extending to the larynx as local cytokine release syndrome following chimeric antigen receptor t-cell therapy in a boy with refractory acute lymphoblastic leukemia"},{"title3":"Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy"},{"title3":"Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with mesothelin-targeted CAR-T cells"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]}]},{"title1":"A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection","References":[{"title2":"Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy","References":[{"title3":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Disease (COVID-19):Chinese, 2020. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Accessed March 22, 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response [e-pub ahead of print. JAMA. https://doi.org/10.1001/jama.2020.4031. Accessed March 24, 2020."},{"title3":"Guidelines on the Therapeutic and Support Management of Patients with COVID-19 Coronavirus Infection. Edition 2.0, 12 March 2020. Available at: http://www.simit.org/medias/1568-covid19-vademecum-20.13.marzo.2020.pdf. Accessed March 22, 2020"},{"title3":"World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed March 22, 2020."},{"title3":"Naicker S, Yang C, Hwang S, et al. The novel Coronavirus 2019 pandemic and kidneys. Kidney Int, in press."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]"},{"title3":"Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 [e-pub ahead of print]. J Crit Care. https://doi.org/10.1016/j.jcrc.2020.03.005. Accessed March 23, 2020."},{"title3":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells"},{"title3":"Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression [e-pub ahead of print]. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkaa114. Accessed March 23, 2020."},{"title3":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [e-pub ahead of print]. Int J Antimicrob Agents. doi: 10.1016/j.ijantimicag.2020.105949. Accessed March 23, 2020."},{"title3":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282. Accessed March 22, 2020."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection"},{"title3":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [e-pub ahead of print]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994. Accessed March 22, 2020."},{"title3":"Cytokine release syndrome with chimeric antigen receptor T cell therapy"}]},{"title2":"COVID-19 and the inpatient dialysis unit: managing resources during contingency planning pre-crisis","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","References":[{"title3":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282. Accessed March 22, 2020."},{"title3":"Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy"},{"title3":"The Novel Coronavirus Pneumoniae Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19):China. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51. Accessed March 22, 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [e-pub ahead of print]. Int J Antimicrob Agents.https://doi.org/10.1016/j.ijantimicag.2020.105949. Accessed March 26, 2020."},{"title3":"Cytokine release syndrome with chimeric antigen receptor T cell therapy"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"}]},{"title2":"COVID-19 infection in kidney transplant recipients","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines","References":[]},{"title2":"Epidemiology of Covid-19 in a long-term care facility in King County, Washington","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"COVID-19 in a long-term care facility : King County, Washington, February 27-March 9, 2020"},{"title3":"The REDCap Consortium: Building an International Community of Software Platform Partners."},{"title3":"Severe respiratory illness outbreak associated with human coronavirus NL63 in a long-term care facility."},{"title3":"Influenza in long-term care facilities."},{"title3":"Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility : King County, Washington, March 2020."},{"title3":". Proclamations re: Covid-19 ()."},{"title3":". Coronavirus disease 2019 (COVID-19) fact sheets ()."},{"title3":". Recommendations for long-term care facility directors re: COVID-19. March 10, 2020 ()."},{"title3":". Preparing for COVID-19: long-term care facilities, nursing homes. 2020 ()."}]}]},{"title1":"SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria","References":[{"title2":"health security for a coronavirus epidemic","References":[{"title3":"Emerging respiratory tract infections"},{"title3":"Emerging and reemerging infectious diseases: global overview"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Toning down the 2019-nCoV hype - and restoring hope"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America"},{"title3":"Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19"},{"title3":"Covid-19: a puzzle with many missing pieces"},{"title3":"2019-nCoV in context: lessons learned?"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"WHO Scientific and Technical Advisory Group for infectious hazards. COVID-19: what is next for public health?"},{"title3":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option"}]},{"title2":"Coronavirus disease 2019 (COVID-19): a critical care perspective beyond China","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Strengthening ICU health security for a coronavirus epidemic"},{"title3":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Situations Leading to Reduced Effectiveness of Current Hand Hygiene against Infectious Mucus from Influenza Virus-Infected Patients"},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection"},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome"},{"title3":"The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases"},{"title3":"Should noninvasive ventilation be considered a high-risk procedure during an epidemic?"},{"title3":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1 v"}]},{"title2":"Potential legal liability for withdrawing or withholding ventilators during COVID-19: assessing the risks and identifying needed reforms","References":[]},{"title2":"Covid-19 in critically Ill patients in the Seattle Region - Case Series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Covid-19 Does Not Lead to a &quot;Typical&quot; Acute Respiratory Distress Syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance, V., 1.2","References":[]},{"title2":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain","References":[{"title3":"Pandemic (H1N1) 2009. Update 62"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009"},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009"},{"title3":"Situation Report. Pandemic Influenza (H1N1) 2009"},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization, April 2009"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults"},{"title3":"Viral pneumonia due to influenza and parainfluenza viruses and adenoviruses"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure"},{"title3":"Vigilancia de la gripe en Espana"},{"title3":"Life-threatening respiratory failure from H1N1 influenza 09 (human swinw influenza)"},{"title3":"Influenza A virus infection and pulmonary microthormboembolism"},{"title3":"Seasonal influenza in adults and children- diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Disease society of America"},{"title3":"Update on avian influenza A (H5N1) virus infection in humans"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"}]},{"title2":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis","References":[{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":" National Health Commission of the People's Republic of China. 2020 Apr 5 [cited 2020 Apr 21]; Available from: . "},{"title3":" World Health Organization website. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of December 31, 2003). 2015 Jul 24 [cited Sep 15]; Available from: . "},{"title3":" World Health Organization website. Middle East respiratory coronavirus syndrome (MERS-COV). 2019 Janu 19 [cited Sep 14]; Available from: . "},{"title3":"Coronavirus infections:more than just the common cold"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":" Coronavirus disease (COVID-19) outbreak. 2020 Dec 11 [cited 2020 Sep 13]. Available from: . "},{"title3":" Coronavirus disease 2019 (COVID-19) Situation Report - 66. 2020 Mar 26 [cited 2020 Sep 17]. Available from: . "},{"title3":" Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020 Feb 24 [cited 2020 Sep 16]. Available from: . "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series"},{"title3":"Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults"},{"title3":" Reported cases and deaths by country, territory, or conveyance. 2020 Apr 10 [cited 2020 Apr 11]; Available from: . "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement"},{"title3":"A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study"},{"title3":"Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms"},{"title3":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China"},{"title3":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy"},{"title3":"Clinical features of cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"COVID-19 with different severities: a multicenter study of clinical features"},{"title3":"Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China"},{"title3":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread"},{"title3":" Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and clinical characteristics of 17 hospitalized patients with 2019 Novel Coronavirus infections outside Wuhan, China. medRxiv [Internet] 2020; Available from; doi.org/10.1101/2020.02.11.20022053. "},{"title3":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China"},{"title3":"Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: a retrospective single center study"},{"title3":"Clinical and transmission characteristics of Covid-19:a retrospective study of 25 cases from a single thoracic surgery department"},{"title3":"Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan"},{"title3":"Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children"},{"title3":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients"},{"title3":"Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study"},{"title3":"Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Characteristics of COVID-19 infection in Beijing"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast Chongqing"},{"title3":"The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China"},{"title3":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China"},{"title3":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China"},{"title3":" Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. [Internet] 2020; Available from: . "},{"title3":"Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features"},{"title3":"Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"The characteristics and clinical value of chest CT images of novel coronavirus pneumonia"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study"},{"title3":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia"}]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 49. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Last accessed, March 9, 2020."},{"title3":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?"},{"title3":"Toward a holistic approach for diagnosing sepsis in the emergency department"},{"title3":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Laboratory abnormalities in patients with COVID-2019 infection"},{"title3":"Association of procalcitonin value and bacterial coinfections in pediatric patients with viral lower respiratory tract infections admitted to the pediatric intensive care unit"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","References":[{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine"},{"title3":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey"}]},{"title2":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","References":[]}]},{"title1":"Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Severe outcomes among patients with Coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Clinical findings in 111 cases of influenza A (H7N9) virus infection","References":[]},{"title2":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"Comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit","References":[]},{"title2":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","References":[]},{"title2":"Cryptic transmission of SARS-CoV-2 in Washington State","References":[{"title3":"A distinct name is needed for the new coronavirus"},{"title3":"A. Rambaut, Phylogenetic analysis of nCoV-2019 genomes (Virological, 2020); https://virological.org/t/phylodynamic-analysis-176-genomes-6-mar-2020/356."},{"title3":"World Health Organization (WHO), &quot;Coronavirus disease 2019 (COVID-19): Situation report - 55&quot; (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_8."},{"title3":"F. Schlosser, B. F. Maier, O. Baranov, D. Brockmann, C. Jongen, A. Zachariae, A. Rose, Coronavirus COVID-19 Global Risk Assessment, Event Horizon - COVID-19 (2020); http://rocs.hu-berlin.de/corona/."},{"title3":"World Health Organization (WHO), &quot;Coronavirus disease 2019 (COVID-19): Situation report - 38&quot; (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19.pdf?sfvrsn=2db7a09b_4."},{"title3":"K. Bray, &quot;Coronavirus update: Addressing questions about a presumptive positive case in an adolescent&quot; (Snohomish Health District Public Health Essentials, 2020); www.snohd.org/Blog.aspx?IID=13."},{"title3":"Washington State Department of Health, &quot;2019 Novel Coronavirus Outbreak (COVID-19)&quot; (2020); www.doh.wa.gov/Emergencies/Coronavirus."},{"title3":"GISAID: Global initiative on sharing all influenza data - from vision to reality"},{"title3":"Data, disease and diplomacy: GISAID's innovative contribution to global health"},{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"N. Imai, I. Dorigatti, A. Cori, C. Donnelly, S. Riley, N. M. Ferguson, &quot;Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China&quot; (Imperial College London, 2020); http://hdl.handle.net/10044/1/77150."},{"title3":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology"},{"title3":"Viral phylodynamics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Serial interval of novel coronavirus (COVID-19) infections"},{"title3":"A Smartphone-Driven Thermometer Application for Real-time Population- and Individual-Level Influenza Surveillance"},{"title3":"U.S. Centers for Disease Control and Prevention (CDC), &quot;Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV)&quot; (CDC Health Alert Network, 2020); https://emergency.cdc.gov/han/han00427.asp."},{"title3":"U.S. Centers for Disease Control and Prevention (CDC), &quot;Criteria to Guide Evaluation of Persons Under Investigation (PUI) for 2019-nCoV&quot; (CDC, 2020); https://web.archive.org/web/20200222215422/https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html."},{"title3":"Introductions and early spread of SARS-CoV-2 in the New York City area"},{"title3":"Coast-to-coast spread of SARS-CoV-2 during the early epidemic in the United States."},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)"},{"title3":"Nextstrain: Real-time tracking of pathogen evolution"},{"title3":"LB21. The Seattle Flu Study: A Community-Based Study of Influenza"},{"title3":"Rapid Metagenomic Next-Generation Sequencing during an Investigation of Hospital-Acquired Human Parainfluenza Virus 3 Infections"},{"title3":"Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6"},{"title3":"Ultrasensitive Capture of Human Herpes Simplex Virus Genomes Directly from Clinical Samples Reveals Extraordinarily Limited Evolution in Cell Culture"},{"title3":"SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing"},{"title3":"M. Vasimuddin, S. Misra, H. Li, S. Aluru, &quot;Efficient architecture-aware acceleration of BWA-MEM for multicore systems,&quot; in 2019 IEEE International Parallel and Distributed Processing Symposium (IPDPS) (IEEE, 2019), pp. 314-324."},{"title3":"Prokka: Rapid prokaryotic genome annotation"},{"title3":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability"},{"title3":"IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies"},{"title3":"Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10"},{"title3":"Dating of the human-ape splitting by a molecular clock of mitochondrial DNA"},{"title3":"A. Doucet, N. de Freitas, N. Gordon, in Sequential Monte Carlo Methods in Practice. Statistics for Engineering and Information Science, A. Doucet, N. de Freitas, N. Gordon, Eds. (Springer, 2001), pp. 3-14."},{"title3":"Novel approach to nonlinear/non-Gaussian Bayesian state estimation"}]},{"title2":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease","References":[{"title3":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans."},{"title3":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans."},{"title3":"Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009."},{"title3":"Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009."},{"title3":"Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009."},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada."},{"title3":"Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009, July 2009-update, 7 July 2009."},{"title3":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand."},{"title3":"2000 CDC growth charts for the United States: Methods and development."},{"title3":"A SAS Program for CDC Growth Charts."},{"title3":"Assessment of child and adolescent overweight and obesity."},{"title3":"Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health."},{"title3":"Obesity: preventing and managing the global epidemic."},{"title3":"Severe Novel Influenza A (H1N1) Virus Infection in the United States, April-May 2009."},{"title3":"CDC protocol of realtime RTPCR for influenza A (H1N1)."},{"title3":"Prevalence of overweight and obesity in the United States, 1999-2004."},{"title3":"What do case-control studies estimate? Survey of methods and assumptions in published case-control research."},{"title3":"Essentials of Medical Statistics."},{"title3":"Introduction to Variance Estimation."},{"title3":"Impact of overweight and obesity on hospitalization: race and gender differences."},{"title3":"Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study."},{"title3":"Effect of obesity on intensive care morbidity and mortality: a meta-analysis."},{"title3":"A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women."},{"title3":"Prevalence and trends in obesity among US adults, 1999-2008."},{"title3":"NCHS data brief no 1. Obesity among adults in the United States-no change since 2003-2004."}]},{"title2":"A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1)","References":[]},{"title2":"Diabetes mellitus, hypertension, and death among 32 patients with MERS-CoV infection, Saudi Arabia","References":[{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."},{"title3":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study."},{"title3":"Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia."},{"title3":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014."}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","References":[]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","References":[]},{"title2":"Arguments in favour of remdesivir for treating SARS-CoV-2 infections","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Emerging threats from zoonotic coronaviruses:from SARS and MERS to 2019-nCoV"},{"title3":"Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group. bioRxiv preprint doi: 10.1101/2020.02.07.937862."},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Chloroquine for the 2019 novel coronavirus"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f] [triazin-4-amino] adenine c-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses"},{"title3":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First case of 2019 novel coronavirus in the United States"}]}]}]}